Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...

Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) reached a new 52-week high on Wednesday after Canaccord Genuity Group raised their price target on the stock from $44.00 to $72.00.

Omeros Corporation today announced the availability on its website of materials accompanying two presentations given at the 2025 Tandem Meetings ? the Transplantation & Cellular Therapy Meetings of ...